These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34921078)

  • 1. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study.
    Nasreen S; Calzavara AJ; Sundaram ME; MacDonald SE; Righolt CH; Pai M; Field TS; Zhou LW; Wilson SE; Kwong JC
    BMJ Open; 2021 Dec; 11(12):e052019. PubMed ID: 34921078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
    Nasreen S; Calzavara A; Buchan SA; Thampi N; Johnson C; Wilson SE; Kwong JC;
    Vaccine; 2022 May; 40(24):3305-3312. PubMed ID: 35527057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thrombotic events and events of special interest in a retrospective cohort of commercially insured US patients.
    Weller SC; Porterfield L; Davis J; Wilkinson GS; Chen L; Baillargeon J
    BMJ Open; 2022 Feb; 12(2):e054669. PubMed ID: 35140157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.
    Silverstein MD; Heit JA; Mohr DN; Petterson TM; O'Fallon WM; Melton LJ
    Arch Intern Med; 1998 Mar; 158(6):585-93. PubMed ID: 9521222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine safety in Scotland - background rates of adverse events of special interest.
    Cullen LA; Grange Z; Antal K; Waugh L; Alsina MS; Gibbons CL; MacDonald LE; Robertson C; Cameron JC; Stockton D; O'Leary MC
    Public Health; 2023 Nov; 224():1-7. PubMed ID: 37688806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
    Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine.
    Huh K; Na Y; Kim YE; Radnaabaatar M; Peck KR; Jung J
    J Korean Med Sci; 2021 Jul; 36(27):e197. PubMed ID: 34254476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute mental health service use following onset of the COVID-19 pandemic in Ontario, Canada: a trend analysis.
    Saunders NR; Toulany A; Deb B; Strauss R; Vigod SN; Guttmann A; Chiu M; Huang A; Fung K; Chen S; Kurdyak P
    CMAJ Open; 2021; 9(4):E988-E997. PubMed ID: 34785528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in the Chinese population--experience in a regional hospital in Hong Kong.
    Liu HS; Kho BC; Chan JC; Cheung FM; Lau KY; Choi FP; Wu WC; Yau TK
    Hong Kong Med J; 2002 Dec; 8(6):400-5. PubMed ID: 12459595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
    Sundaram M; Nasreen S; Calzavara A; He S; Chung H; Bronskill SE; Buchan SA; Tadrous M; Tanuseputro P; Wilson K; Wilson S; Kwong JC;
    Vaccine; 2021 Aug; 39(37):5265-5270. PubMed ID: 34373124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
    Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
    Li X; Ostropolets A; Makadia R; Shoaibi A; Rao G; Sena AG; Martinez-Hernandez E; Delmestri A; Verhamme K; Rijnbeek PR; Duarte-Salles T; Suchard MA; Ryan PB; Hripcsak G; Prieto-Alhambra D
    BMJ; 2021 Jun; 373():n1435. PubMed ID: 35727911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    Lo Re V; Dutcher SK; Connolly JG; Perez-Vilar S; Carbonari DM; DeFor TA; Djibo DA; Harrington LB; Hou L; Hennessy S; Hubbard RA; Kempner ME; Kuntz JL; McMahill-Walraven CN; Mosley J; Pawloski PA; Petrone AB; Pishko AM; Driscoll MR; Steiner CA; Zhou Y; Cocoros NM
    JAMA; 2022 Aug; 328(7):637-651. PubMed ID: 35972486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.
    Ward A; Sarraju A; Lee D; Bhasin K; Gad S; Beetel R; Chang S; Bonafede M; Rodriguez F; Dash R
    PLoS One; 2022; 17(1):e0261786. PubMed ID: 35020742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis.
    Banga S; Khromava A; Serradell L; Chabanon AL; Pan C; Estevez I; Schilsky S; Kreisberg H
    BMJ Open; 2024 Jul; 14(7):e083947. PubMed ID: 38991681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic.
    Müllerová H; Medin J; Arnold M; Gomes da Silva H; Kumar S; Nord M; Hubbard R; de Lusignan S
    BMJ Open; 2023 Jan; 13(1):e063645. PubMed ID: 36639216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
    Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
    Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-Level Trends in Emergency Department Encounters for Sexual Assault Preceding and During the COVID-19 Pandemic Across Ontario, Canada.
    Muldoon KA; Talarico R; Fell DB; Illingworth H; Sampsel K; Manuel DG
    JAMA Netw Open; 2022 Dec; 5(12):e2248972. PubMed ID: 36580330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.
    Voss EA; Shoaibi A; Yin Hui Lai L; Blacketer C; Alshammari T; Makadia R; Haynes K; Sena AG; Rao G; van Sandijk S; Fraboulet C; Boyer L; Le Carrour T; Horban S; Morales DR; Martínez Roldán J; Ramírez-Anguita JM; Mayer MA; de Wilde M; John LH; Duarte-Salles T; Roel E; Pistillo A; Kolde R; Maljković F; Denaxas S; Papez V; Kahn MG; Natarajan K; Reich C; Secora A; Minty EP; Shah NH; Posada JD; Garcia Morales MT; Bosca D; Cadenas Juanino H; Diaz Holgado A; Pedrera Jiménez M; Serrano Balazote P; García Barrio N; Şen S; Üresin AY; Erdogan B; Belmans L; Byttebier G; Malbrain MLNG; Dedman DJ; Cuccu Z; Vashisht R; Butte AJ; Patel A; Dahm L; Han C; Bu F; Arshad F; Ostropolets A; Nyberg F; Hripcsak G; Suchard MA; Prieto-Alhambra D; Rijnbeek PR; Schuemie MJ; Ryan PB
    EClinicalMedicine; 2023 Apr; 58():101932. PubMed ID: 37034358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
    Shazley O; Alshazley M
    Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.